Skip to main content
Log in

CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Pittner BT, Shanafelt TD, Kay NE, Jelinek DF . CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation. Leukemia 2005; 19: 2264–2272.

    Article  CAS  PubMed  Google Scholar 

  2. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847.

    CAS  PubMed  Google Scholar 

  3. Rose DM, Han J, Ginsberg MH . Alpha4 integrins and the immune response. Immunol Rev 2002; 186: 118–124.

    Article  CAS  PubMed  Google Scholar 

  4. Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Russo S et al. Signature of B-CLL with different prognosis by shrunken centroids of surface antigen expression profiling. J Cell Physiol 2005; 204: 113–123.

    Article  CAS  PubMed  Google Scholar 

  5. Bomben R, Dal Bo M, Zucchetto A, Zaina E, Nanni P, Sonego P et al. Mutational status of IgV(H) genes in B-cell chronic lymphocytic leukemia and prognosis: percent mutations or antigen-driven selection? Leukemia 2005; 19: 1490–1492.

    Article  CAS  PubMed  Google Scholar 

  6. Degan M, Bomben R, Dal Bo M, Zucchetto A, Nanni P, Rupolo M et al. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery. Br J Haematol 2004; 126: 29–42.

    Article  CAS  PubMed  Google Scholar 

  7. Eksioglu-Demiralp E, Alpdogan O, Aktan M, Firatli T, Ozturk A, Budak T et al. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages. Leukemia 1996; 10: 1331–1339.

    CAS  PubMed  Google Scholar 

  8. de la Fuente MT, Casanova B, Cantero E, Hernandez DC, Garcia-Marco J, Silva A et al. Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine. Biochem Biophys Res Commun 2003; 311: 708–712.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by Ministero della Salute (Ricerca Finalizzata IRCCS and ‘Alleanza Contro il Cancro’), Rome, Italy.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zucchetto, A., Bomben, R., Dal Bo, M. et al. CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance. Leukemia 20, 523–525 (2006). https://doi.org/10.1038/sj.leu.2404087

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404087

  • Springer Nature Limited

This article is cited by

Navigation